These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 18521011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo.
    Pernet V, Di Polo A.
    Brain; 2006 Apr; 129(Pt 4):1014-26. PubMed ID: 16418178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optic nerve and neuroprotection strategies.
    Osborne NN, Chidlow G, Layton CJ, Wood JP, Casson RJ, Melena J.
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [Abstract] [Full Text] [Related]

  • 7. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
    Wilson AM, Di Polo A.
    Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS.
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [Abstract] [Full Text] [Related]

  • 10. The molecular basis of retinal ganglion cell death in glaucoma.
    Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A.
    Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R, Peeples P, Walt JG, Bramley TJ.
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [Abstract] [Full Text] [Related]

  • 13. Current and emerging medical therapies in the treatment of glaucoma.
    Bagnis A, Papadia M, Scotto R, Traverso CE.
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
    [Abstract] [Full Text] [Related]

  • 14. Different optic nerve injury sites result in different responses of retinal ganglion cells to brain-derived neurotrophic factor but not neurotrophin-4/5.
    Zhi Y, Lu Q, Zhang CW, Yip HK, So KF, Cui Q.
    Brain Res; 2005 Jun 21; 1047(2):224-32. PubMed ID: 15904902
    [Abstract] [Full Text] [Related]

  • 15. Glaucoma as a neurodegenerative disease.
    Gupta N, Yücel YH.
    Curr Opin Ophthalmol; 2007 Mar 21; 18(2):110-4. PubMed ID: 17301611
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV.
    Curr Opin Ophthalmol; 2011 Mar 21; 22(2):78-86. PubMed ID: 21252670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.